Gilead Sciences (GILD) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $569.0 million.
- Gilead Sciences' Non Operating Income rose 8594.77% to $569.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $414.0 million, marking a year-over-year increase of 2358.21%. This contributed to the annual value of $6.0 million for FY2024, which is 9696.97% down from last year.
- According to the latest figures from Q3 2025, Gilead Sciences' Non Operating Income is $569.0 million, which was up 8594.77% from $208.0 million recorded in Q2 2025.
- Over the past 5 years, Gilead Sciences' Non Operating Income peaked at $569.0 million during Q3 2025, and registered a low of -$369.0 million during Q1 2021.
- In the last 5 years, Gilead Sciences' Non Operating Income had a median value of -$72.0 million in 2023 and averaged -$29.7 million.
- In the last 5 years, Gilead Sciences' Non Operating Income surged by 303000.0% in 2023 and then tumbled by 46043.96% in 2025.
- Gilead Sciences' Non Operating Income (Quarter) stood at $57.0 million in 2021, then plummeted by 117.54% to -$10.0 million in 2022, then skyrocketed by 3030.0% to $293.0 million in 2023, then tumbled by 111.95% to -$35.0 million in 2024, then skyrocketed by 1725.71% to $569.0 million in 2025.
- Its Non Operating Income stands at $569.0 million for Q3 2025, versus $208.0 million for Q2 2025 and -$328.0 million for Q1 2025.